CD4+ T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19

Jie Zhang,Chun Chang,Zhaoyuan Liang,Tingting Hu,Zhongnan Yin,Ying Liang,Ting Zhang,Yanling Ding,Xianlong Li,Xiaoyan Gai,Xiaoxue Yang,Xin Li,Xixuan Dong,Jiaqi Ren,Yafei Rao,Jun Wang,Jianling Yang,Lixiang Xue,Yongchang Sun

DOI: https://doi.org/10.1101/2023.08.04.551565

2023-01-01

Abstract:Background Aging is a critical risk factor for unfavorable clinical outcomes among COVID-19 patients and may affect vaccine efficacy. However, whether the senescence of T cells impact the progression to severe COVID-19 in the elderly individuals remains unclear. Methods By using flow cytometry, we analyzed the frequency of senescent T cells (Tsens) in the peripheral blood from 100 elderly patients hospitalized for COVID-19 and compared the difference between mild/moderate and severe/critical illness. We also assessed correlations between the percentage of Tsens and the quantity and quality of spike-specific antibodies by ELISA, neutralizing antibody test kit and Elispot assay respectively, cytokine production profile of COVID-19 reactive T cells as well as plasma soluble factors by cytometric bead array (CBA). Results We found a significant elevated level of CD4+ Tsens in severe/critical disease compared to mild/moderate illness and patients with a higher level of CD4+ Tsens (>19.78%) showed a decreased survival rate as compared to those with a lower level (<19.78%), especially in the breakthrough infection. The percentage of CD4+ Tsens was negatively correlated with spike-specific antibody titers, neutralization ability and COVID-19 reactive IL-2+ CD4+ T cells. Additionally, IL-2 producing T cells and plasma levels of IL-2 were positively correlated with antibody levels. Conclusion Our data illustrated that the percentage of CD4+ Tsens in the peripheral blood could act as an efficient biomarker for the capacity of spike-specific antibody production and the prognosis of severe COVID-19, especially in the breakthrough infection. Therefore, restoration of the immune response of CD4+ Tsens is one of the key factors to prevent severe illness and improve vaccine efficacy in older adults. ### Competing Interest Statement The authors have declared no competing interest. * ACE : angiotensin converting enzyme BMI : body mass index CD : cluster of differentiation COVID : corona virus disease CBA : cytometric bead array CRP : C-reactive protein CM : central memory COPD : chronic obstructive pulmonary disease CXCL : C-X-C motif ligand CCL : C-C motif ligand DC : dendritic cells ELISA : enzyme-linked immunosorbent assay Elispot : enzyme-linked immunoblot EM : effector memory EMRA : terminally differentiated effector cells EDTA : ethylene diamine tetraacetic acid IL : interleukin ICU : intensive care unit IgG : immunoglobulin G IgM : immunoglobulin M IFN-γ : interferon-γ LDH : lactate dehydrogenase PCT : procalcitonin PLT : platelet PBMCs : peripheral blood mononuclear cells RBD : receptor binding domain RBC : red blood cell RR : respiratory rate SARS-CoV-2 : severe acute respiratory syndrome coronavirus 2 SASP : senescent associated secretory phenotype Tsens : senescent T cells TNF-α : tumor necrosis factor Th : helper T cells WT : wild type